Evidence map›Paper›PMID 26949255›Full record

ArticleeLife2016

No current evidence for widespread dosage compensation in S. cerevisiae.

Eduardo M Torres, Michael Springer, Angelika Amon

Abstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Transcriptomic and proteomic ramifications of segmental amplification inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Targeting chromosomal instability in patients with cancer.Nature reviews. Clinical oncology · 2024
    Review
  8. Article
  9. A survey of chromosomal instability measures across mechanistic models.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Consequences of gaining an extra chromosome.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2023
    Review
  14. Article
  15. Article
  16. A survey of CIN measures across mechanistic models.bioRxiv : the preprint server for biology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eduardo M TorresDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States.
Michael SpringerDepartment of Systems Biology, Harvard Medical School, Boston, United States.
Angelika AmonDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States.

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Regulation of Mitosis by Proteolysis in YeastR01GM056800 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI AMON, ANGELIKA B · 2004 to 2015
$3.4M
Causes and consequences of aneuploidyR35GM118066 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI AMON, ANGELIKA B · 2016 to 2020
$1.9M
Role of de Novo Synthesis of Sphingolipids in Aneuploid CellsR01GM118481 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TORRES, EDUARDO MARTIN · 2017 to 2021
$1.7M
Regulation of mitosis by proteolysis in yeastR01CA206157 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI AMON, ANGELIKA B · 2016 to 2020
$1.4M
REGULATION OF MITOSIS BY PROTEOLYSIS IN YEASTR29GM056800 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI AMON, ANGELIKA B · 1997 to 2003
$738k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA014051NCI NIH HHS R01 CA206157NIGMS NIH HHS R01 GM056800NIGMS NIH HHS R01 GM118481NIGMS NIH HHS R29 GM056800NIGMS NIH HHS R35 GM118066
6 · The paper itself

Abstract

Previous studies of laboratory strains of budding yeast had shown that when gene copy number is altered experimentally, RNA levels generally scale accordingly. This is true when the copy number of individual genes or entire chromosomes is altered. In a recent study, Hose et al. (2015) reported that this tight correlation between gene copy number and RNA levels is not observed in recently isolated wild Saccharomyces cerevisiae variants. To understand the origins of this proposed difference in gene expression regulation between natural variants and laboratory strains of S. cerevisiae, we evaluated the karyotype and gene expression studies performed by Hose et al. on wild S. cerevisiae strains. In contrast to the results of Hose et al., our reexamination of their data revealed a tight correlation between gene copy number and gene expression. We conclude that widespread dosage compensation occurs neither in laboratory strains nor in natural variants of S. cerevisiae.

Indexed as

Gene DosageGene Expression Regulation, FungalAneuploidyGene Expression ProfilingKaryotypingRNA, FungalRNA, MessengerSaccharomyces cerevisiaeRNA, FungalRNA, Messengeraneuploidycell biologychromosomesdosage compensationgene expressiongenesS. cerevisiae

Identifiers

PMID26949255
PMCPMC4798953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.